Grade D esophagitis is the most severe form of erosive esophagitis on the Los Angeles (LA) classification scale, defined by mucosal breaks that wrap around at least 75 percent of the esophageal circumference. It represents serious damage to the lining of the esophagus, and its clinical profile is surprisingly distinct from milder grades. Research suggests that Grade D is not simply “worse reflux” but may involve factors beyond typical gastroesophageal reflux disease, making it a condition that demands careful diagnosis, aggressive treatment, and long-term follow-up.
What the LA Classification Means and Where Grade D Sits
Doctors grade erosive esophagitis during an upper endoscopy using the Los Angeles classification, a four-tier system based on how much of the esophageal lining is damaged. Grade A, the mildest, involves one or more mucosal breaks no longer than 5 mm that do not extend between the tops of two mucosal folds. Grades B and C represent progressively wider and longer breaks. Grade D, at the top, is diagnosed when mucosal breaks cover 75 percent or more of the esophageal circumference.1Journal of Clinical Gastroenterology. Unique Clinical Features of Los Angeles Grade D Esophagitis Suggest that Factors Other than Gastroesophageal Reflux Contribute to Its Pathogenesis That level of damage means the esophagus is nearly circumferentially inflamed or ulcerated, which is why Grade D carries a higher risk of complications and typically requires more intensive management.
A Different Kind of Patient
One of the more striking findings in the literature is that people diagnosed with Grade D esophagitis do not look like typical reflux patients. In a study comparing LA-D to LA-A patients, those with Grade D had a significantly lower average body mass index and were less likely to have a prior history of gastroesophageal reflux disease. Only about 45 percent of Grade D patients had a documented GERD history, compared to 67 percent of Grade A patients.2PubMed Central. Unique Clinical Features of Los Angeles Grade D Esophagitis Suggest that Factors Other than Gastroesophageal Reflux Contribute to Its Pathogenesis This turns the usual assumption on its head: you might expect the worst esophageal damage to show up in people with the longest, most severe reflux, but that often is not the case.
Perhaps even more telling, 70 percent of patients with Grade D esophagitis were hospitalized at the time of their diagnosis, either on a medical ward or in an intensive care unit, compared to just 3 percent of Grade A patients.2PubMed Central. Unique Clinical Features of Los Angeles Grade D Esophagitis Suggest that Factors Other than Gastroesophageal Reflux Contribute to Its Pathogenesis This suggests that Grade D esophagitis frequently develops in the context of acute illness, critical care, or other systemic stressors rather than chronic, slowly worsening acid reflux. Medications that weaken mucosal defenses, prolonged fasting, nasogastric tubes, and reduced consciousness can all contribute to severe esophageal injury in hospitalized patients.
Hiatal hernia, often considered a hallmark of reflux-related esophagitis, was actually seen less frequently in Grade D patients than in Grade A patients in the same study, though the difference did not quite reach statistical significance.2PubMed Central. Unique Clinical Features of Los Angeles Grade D Esophagitis Suggest that Factors Other than Gastroesophageal Reflux Contribute to Its Pathogenesis Taken together, these findings point to a condition where the usual risk profile for reflux disease does not fully explain what is going on.
Symptoms Can Be Misleading
Erosive esophagitis, including severe forms, typically stems from the failure of the lower esophageal sphincter to keep stomach acid out of the esophagus.3European Journal of Scientific Research and Reviews. Comparative Pharmacology of Erosive Esophagitis: Proton Pump Inhibitors, H2 Blockers, Antacids, Mucosa Protective Agent and Potassium Competitive Blocker The resulting acid exposure can cause symptoms ranging from chest discomfort and abdominal pain to coughing and wheezing.4PubMed Central. Pulmonary manifestations of gastroesophageal reflux disease Difficulty swallowing and painful swallowing were reported as the reason for endoscopy in about 20 percent of Grade D cases.2PubMed Central. Unique Clinical Features of Los Angeles Grade D Esophagitis Suggest that Factors Other than Gastroesophageal Reflux Contribute to Its Pathogenesis
But here is a common and clinically important misconception: worse damage does not always mean worse heartburn. A large study found that the prevalence of severe erosive esophagitis increases with each decade of life, rising from about 12 percent in patients under 21 to 37 percent in patients over 70. Yet among those with severe disease, the proportion who reported severe heartburn dropped dramatically with age, from 82 percent in the youngest group to just 34 percent in the oldest.5PubMed. Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease In other words, older adults can have extensive esophageal damage with relatively mild or even absent heartburn. If you are over 60 and have been told your mild reflux symptoms are nothing to worry about, that reassurance may not tell the whole story. The authors of that study concluded that more aggressive investigation may be necessary for elderly patients regardless of how their heartburn feels.
Treatment With Acid-Suppressing Medications
The cornerstone of treatment for Grade D esophagitis is potent acid suppression. Current guidelines from the American College of Gastroenterology recommend that patients with LA Grade C or D erosive esophagitis remain on long-term proton pump inhibitor (PPI) therapy to maintain healing.6PubMed Central. ACG Clinical Guideline: Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease This is different from milder grades, where a doctor might try stepping down or stopping medication after the esophagus heals. With Grade D, the risk of relapse is high enough that ongoing treatment is considered standard.
The reasoning is straightforward: the more severe the initial damage, the more likely it is to come back once medication stops. Research on maintenance therapy found that patients whose esophagitis required longer courses of treatment to heal in the first place relapsed more often, and patients with more severe initial disease had significantly more relapses than those with mild disease.7Clinical Therapeutics. Factors predicting relapse during maintenance treatment with famotidine in patients with healed reflux esophagitis Grade D, by definition, is as severe as it gets.
An older but influential head-to-head trial comparing five maintenance strategies showed that omeprazole, a first-generation PPI, kept about 80 percent of patients in remission at 12 months, while weaker acid-suppressing drugs like ranitidine or cisapride alone kept only about half in remission.8PubMed. A comparison of five maintenance therapies for reflux esophagitis The gap was large enough that PPIs became the default long-term therapy for severe erosive disease.
Newer Alternatives to PPIs
A newer class of drugs called potassium-competitive acid blockers (P-CABs) has emerged as a potentially stronger option, particularly for severe cases. Vonoprazan, the best-studied P-CAB, works through a different mechanism than PPIs and produces faster, more consistent acid suppression. In a randomized trial, vonoprazan was superior to the PPI lansoprazole for healing Grade C and D esophagitis at two weeks, with a difference of roughly 18 percentage points in healing rates.9PubMed. Vonoprazan Versus Lansoprazole for Healing and Maintenance of Healing of Erosive Esophagitis: A Randomized Trial
A systematic review and network meta-analysis confirmed the pattern: P-CABs as a class were associated with significantly higher healing rates compared to PPIs, with vonoprazan ranking near the top among all treatments studied.10PubMed Central. Potassium-competitive Acid Blockers Versus Proton Pump Inhibitors for Erosive Esophagitis: A Systematic Review and Network Meta-analysis A Korean expert review reached the same conclusion, noting that P-CABs demonstrate rapid onset and superior healing in severe erosive esophagitis, along with higher endoscopic remission rates during maintenance therapy.11PubMed Central. Potassium-competitive Acid Blockers in Gastroesophageal Reflux Disease and Functional Dyspepsia: A Korean Expert Review With Original Meta-analyses
For patients whose Grade D esophagitis does not heal well or keeps relapsing on a PPI, vonoprazan is a meaningful alternative worth discussing with a gastroenterologist. In a follow-up study of patients whose esophagitis had been resistant to PPI therapy, vonoprazan at a maintenance dose kept about 86 percent free of mucosal recurrence through 96 weeks.12PubMed Central. Follow-up study of vonoprazan maintenance therapy for reflux esophagitis: A 96-week evaluation in patients with PPI-refractory disease That is a strong result for a population that had already failed standard therapy.
Why Follow-Up Endoscopy Matters
After an initial course of treatment, usually eight weeks of high-dose PPI therapy, patients with Grade C or D esophagitis should undergo a repeat endoscopy.13Journal of Translational Gastroenterology. Optimal Management of Erosive Esophagitis: An Evidence-based and Pragmatic Approach There are two reasons for this, and both are important.
First, the doctor needs to confirm that the esophagus has actually healed. If it has not, the treatment plan needs to be adjusted, whether that means a higher dose, a different medication, or a longer course. Second, and perhaps less obvious, severe inflammation can mask Barrett’s esophagus, a condition where the normal esophageal lining is replaced by tissue that resembles the intestinal lining. Barrett’s esophagus is a precursor to a type of esophageal cancer. A study evaluating patients with moderate to severe erosive esophagitis found that Barrett’s was suspected in 48 patients after their esophagitis healed, and biopsy confirmed it in 26 of those cases. The study concluded that Barrett’s esophagus and associated precancerous changes can be missed in the presence of active inflammation, so repeat evaluation after complete healing is important.14PubMed Central. Prevalence of Barrett’s esophagus in patients with moderate to severe erosive esophagitis
Skipping the follow-up endoscopy after Grade D esophagitis is one of the more consequential mistakes a patient or provider can make. The stakes are not just about whether your symptoms come back. They are about catching a precancerous condition early, when it is still manageable.
When Surgery Comes Into the Picture
Most people with Grade D esophagitis will be managed with medications. But for patients who cannot tolerate long-term drug therapy, who have persistent symptoms despite maximal medical treatment, or who prefer a surgical solution, anti-reflux surgery is an option. The most common procedure is Nissen fundoplication, in which the top of the stomach is wrapped around the lower esophagus to reinforce the sphincter.
A large outcomes study comparing patients with complicated erosive esophagitis who had fundoplication against those treated without surgery found that the surgical group had lower rates of recurring esophageal erosions, ulcers, and strictures during follow-up. Erosion recurrence was 46 percent in the surgical group versus 56 percent in the non-surgical group, and stricture recurrence was 32 percent versus 43 percent.15PubMed. Outcome of erosive reflux esophagitis after Nissen fundoplication Surgery does not eliminate recurrence entirely, but it meaningfully reduces it. The decision is highly individual and depends on factors like your overall health, the anatomy of your hernia if you have one, and how well you respond to medications.
Nutritional Consequences of Severe Esophagitis
An underappreciated aspect of Grade D esophagitis is what it does to nutrition. When the esophagus is severely inflamed or narrowed by stricture formation, swallowing becomes painful or mechanically difficult. This impairs the passage of food, and over time, patients can lose a dangerous amount of weight. In cases where esophageal strictures develop, the extent of swallowing difficulty is directly associated with the nutritional deficit.16PubMed Central. Clinical Decision-Making in Peptic Esophageal Stenosis: To PEG or Not to PEG?
Restoring adequate nutrition is not just about feeling better. It is a prerequisite for further treatment planning, including any potential surgery. Malnourished patients face higher rates of postoperative complications and longer recovery times. In severe cases, nutritional support through a feeding tube may be necessary before definitive treatment can proceed. If you are losing weight because of difficulty swallowing, bring it up with your doctor immediately rather than waiting for your next scheduled visit.
Lifestyle Measures and Their Limits
Lifestyle modifications are a staple of reflux management advice, and some have reasonable evidence behind them. In randomized trials, eating earlier in the evening rather than right before bed reduced the time the esophagus was exposed to acid while lying down. Similarly, elevating the head of the bed by about 10 inches with a wedge decreased acid exposure from roughly 21 percent of supine time to about 15 percent.17PubMed Central. Lifestyle intervention in gastroesophageal reflux disease – Section: Results
These interventions are worth trying, and they have essentially no downside. But it is important to be realistic: for Grade D esophagitis specifically, lifestyle changes alone will not heal the esophagus. They are an adjunct to medication, not a replacement. The damage at this grade is severe enough that potent acid suppression is necessary. Think of head-of-bed elevation and meal timing as ways to give the medication a better chance of working, not as standalone treatments.
The Impact on Sleep and Daily Life
Reflux and sleep have a well-documented, bidirectional relationship. Acid reflux worsens at night when you lie flat, and poor sleep can in turn worsen reflux perception. A study of working-aged adults found that erosive esophagitis in men was associated with poor sleep quality, longer time to fall asleep, and interrupted sleep.18Gut and Liver. The Relationship between Erosive Esophagitis and Sleep Issues in Working-Aged Koreans The association did not reach significance in women in that particular study, though the reasons are unclear and may relate to differences in how reflux manifests or how sleep quality was reported.
For someone with Grade D esophagitis, the sleep disruption can be substantial. Nighttime acid exposure is more prolonged, the esophageal inflammation is more extensive, and symptoms like coughing or chest discomfort can wake you repeatedly. Addressing the reflux with appropriate medication and positional measures often improves sleep quality as a secondary benefit.
The Financial Burden
Living with esophageal disease is expensive. A national retrospective study of newly diagnosed erosive esophagitis patients in the United States found that average total disease-related costs were over $4,300 per patient, and total all-cause healthcare costs for patients who had an endoscopy averaged roughly $58,700.19PubMed Central. Economic and treatment burden among newly diagnosed patients with erosive esophagitis in the US: a national retrospective cohort study Those figures capture only the initial period around diagnosis and do not reflect the ongoing costs of long-term PPI or P-CAB therapy, repeated endoscopies, or treatment of complications.
The financial picture gets worse if erosive esophagitis progresses to Barrett’s esophagus or, in rare cases, esophageal cancer. A separate analysis found that disease-related costs for patients with non-dysplastic Barrett’s averaged about $8,750 per year, while costs for esophageal adenocarcinoma reached a mean of roughly $146,000 per year.20PubMed Central. Healthcare Resource Utilization and Costs Among Patients With Gastroesophageal Reflux Disease, Barrett’s Esophagus, and Barrett’s Esophagus-Related Neoplasia in the United States Medical costs made up more than 95 percent of those totals across all disease stages. The economic argument for aggressive early treatment and surveillance of severe esophagitis is hard to ignore.
Older Adults and the Symptom-Severity Disconnect
The evidence on aging and esophagitis severity deserves more attention than it typically gets. As noted earlier, the prevalence of severe erosive esophagitis climbs steadily with age, but the correlation between heartburn intensity and tissue damage falls apart in older populations.5PubMed. Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease Several factors likely contribute. Older adults may have reduced esophageal sensitivity due to nerve changes, they are more likely to take medications that suppress pain perception, and they may attribute symptoms to other conditions or dismiss them as normal aging.
The practical consequence is that relying on symptom severity alone to decide who needs an endoscopy can be dangerously inaccurate in older patients. A 75-year-old with mild, infrequent heartburn could have Grade D esophagitis with near-circumferential mucosal destruction. Guidelines increasingly recognize this gap, and many gastroenterologists now recommend endoscopy for older adults with any reflux symptoms lasting more than a few weeks, along with those who have alarm features like difficulty swallowing, weight loss, or anemia.